Real-time enrollment status for this glycogen storage disease type ii (gsd-ii) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:45 AM UTC
| NCT Number | NCT00567073 |
| Recruiting Status | Recruiting |
| Condition | Glycogen Storage Disease Type II (GSD-II) |
| Phase | Clinical Trial |
| Target Enrollment | 20 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Genzyme, a Sanofi Company |
| Last Updated on CT.gov | April 16, 2026 (Apr 16, 2026) |
As of July 13, 2026: Clinical trial NCT00567073 is currently recruiting participants. This clinical trial study for glycogen storage disease type ii (gsd-ii) is actively seeking new participants at 15 locations across the United States. The study is sponsored by Genzyme, a Sanofi Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT00567073 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT00567073 was last updated Apr 16, 2026 (April 16, 2026). HelloStudys verifies this status automatically.